#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary ataxia Oesophageal squamous cell carcinoma stage III Osteomyelitis Paget's disease of the vulva Cytokine release syndrome Hypomagnesaemia Familial amyotrophic lateral sclerosis Inflammatory myofibroblastic tumour Medulloblastoma recurrent MELAS syndrome Extra-osseous Ewing's sarcoma Becker's muscular dystrophy Congenital megacolon Acute graft versus host disease in skin Gaucher's disease type III More trials…

    Learn about Rare Diseases

    Short-bowel syndrome – Life with Disease MELAS syndrome – Basic Information Hepatic angiosarcoma – Diagnostics Breast angiosarcoma – Life with Disease Castleman’s disease – Diagnostics Alport’s syndrome Ewing’s sarcoma – Life with Disease Sarcoidosis – Life with Disease Testicular leiomyosarcoma Toxic epidermal necrolysis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cln-081 Abiraterone VTX-002 Teprotumumab Lutikizumab Azd8421 Clascoterone Ly3298176 Lidocaine Hydrochloride Ixekizumab Acetylcholine Chloride Specific Nucleic Acid Sna-Xfsa Quinine Dihydrochloride Tasimelteon Riliprubart Ganciclovir Etelcalcetide Exenatide Dinutuximab Beta Dsimc More therapies…

    Learn about Your Condition

    Joint stabilisation Autoimmune disorder Adenosquamous cell lung cancer Retinopathy of prematurity Otitis media Haemorrhoids Glycogen storage disorder Hyperinsulinism Malformation venous Streptococcal infection Choroid melanoma Breast cancer stage I Vaginal infection Post procedural swelling Peritoneal cancer index More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • Study of psilocybin therapy for psychological distress in patients with COPD, ALS, multiple sclerosis, or atypical Parkinson’s disorders

    Recruiting

    2 1 1
    Investigated Drugs:
    • Psilocybine
    Czechia Denmark The Netherlands Portugal

  • Ozone Treatment for Numbness and Tingling from Chemotherapy in Patients with Peripheral Neuropathy: A Clinical Trial

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hypoaesthesia
    • Paraesthesia
    • Neuropathy peripheral
    Investigated Drugs:
    • Oxygen
    Spain

  • Study on Acyclovir for Patients with Herpes Simplex Virus Reactivation in the Throat on Mechanical Ventilation with One or No Organ Failure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Herpes simplex reactivation
    Investigated Drugs:
    • Aciclovir
    • Sodium Chloride
    France

  • Study on Ketamine and Midazolam for Adults with Depression and Alcohol Use Disorder

    Recruiting

    1 1 1
    Investigated Drugs:
    • Ketamine
    • Midazolam Hydrochloride
    Norway

  • Study on the Safety of Using Chemoradiation with Cisplatin and Carboplatin for Early-Stage Vulvar Cancer Patients with Macrometastasis in Sentinel Lymph Node

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Vulval cancer
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    Belgium France The Netherlands Sweden

  • Study on Early Use of Vasopressin and Norepinephrine for Patients with Septic Shock

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Argipressin
    Italy
Previous Page
1 … 6 7 8 9 10 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!